Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 6Pain, Postoperative 5Brain Neoplasms 5Lung Neoplasms 3Delirium 3Uterine Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Kidney Neoplasms 2Depression 2Carcinoma, Non-Small-Cell Lung 2Vomiting 1Thromboembolism 1Synovial Cyst 1Surgical Wound Infection 1Supratentorial Neoplasms 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Spondylosis 1Spondylolisthesis 1Spinal Stenosis 1Sleep Initiation and Maintenance Disorders 1Sleep Deprivation 1Scleroderma, Localized 1Radiculopathy 1Prostatic Neoplasms 1Postoperative Hemorrhage 1Pituitary Neoplasms 1Pituitary Diseases 1Otolaryngeal Cancer 1

Interventions

Aprepitant 8Palonosetron 6Dexamethasone 6Granisetron 3fosaprepitant 2dexamethasone 21-phosphate 2Tropisetron 2Ondansetron 2Metoclopramide 2Calcium Dobesilate 2ramosetron 1naldemedine 1gamma-Aminobutyric Acid 1dolasetron 1dexamethasone acetate 1alizapride 1Tablets 1Spinal Puncture 1Saline Solution 1Population Groups 1Olanzapine 1Myelography 1Duration of Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Vomiting × Saline Solution × Clear all
NCT01432015 2017-03-28

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Gynecologic Oncology Associates

Phase 4 Completed
20 enrolled 5 charts
Gynecologic

Ovarian Neoplasms, Uterine Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡